Glucagon-like peptide-1 receptor agonist use and violent crime among US adults.
The rapid proliferation of Glucagon-like peptide-1 (GLP-1) receptor agonists, marketed under brand names such as Ozempic and Wegovy, has already fundamentally altered the landscape of metabolic health and obesity treatment…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple





